NCT00327106View on ClinicalTrials.gov

Tranexamic Acid in HIp Fracture Surgery (THIF Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Hip Fracture
Interventions
DRUG

Tranexamic acid (Exacyl)

15 mg/kg IV (in the vein), just before surgery and 3 hours after surgery

DRUG

Placebo

NaCl 9‰, 0,15 ml/kg IV (in the vein), just before surgery and 3 hours after surgery.

Trial Locations (1)

42055

Chu Saint-Etienne, Saint-Étienne-de-Montluc

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT00327106 - Tranexamic Acid in HIp Fracture Surgery (THIF Study) | Biotech Hunter | Biotech Hunter